NCAM1 and neoplasm: In addition, the immune cells with tumor-killing effects, such as “activated CD8 T cell”, “CD56 bright natural killer cell” and “effector memory CD8 T cell” were sharply reduced in the high-risk group (Fig. 6F and Sup Fig. 3 A).